Viewing Company
Company Name:
Reviva Pharmaceuticals Holdings, Inc.
CIK:
1742927
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2018-10-11
Last Filing Date:
2025-04-03
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2018-03-20 | 2019-02-28 | CY2019Q1I | 2019-05-22 | 0001144204-19-027771 | $ 2,039,690 | View |
| 2024-07-01 | 2024-09-30 | CY2024Q3I | 2024-11-14 | 0001437749-24-035375 | $ 4,194,957 | View |
| 2020-06-01 | 2020-08-31 | CY2019Q3 | 2020-10-14 | 0001104659-20-114968 | $ 2,742,935 | View |
| 2020-09-01 | 2020-11-30 | CY2020Q4 | 2021-01-14 | 0001104659-21-004303 | $ 2,806,128 | View |
| 2020-01-01 | 2020-12-31 | None | 2021-03-22 | 0001437749-21-006681 | $ 3,061,670 | View |
| 2020-01-01 | 2020-12-31 | CY2019 | 2021-05-07 | 0001437749-21-011375 | $ 3,061,670 | View |
| 2021-01-01 | 2021-03-31 | CY2021Q1 | 2021-05-17 | 0001437749-21-012409 | $ 9,231,737 | View |
| 2022-01-01 | 2022-03-31 | CY2021Q1 | 2022-05-16 | 0001437749-22-012629 | $ 18,466,586 | View |
| 2018-06-01 | 2018-08-31 | CY2018Q3I | 2018-10-11 | 0001144204-18-053514 | $ 1,460,688 | View |
| 2018-09-01 | 2018-11-30 | CY2018Q4I | 2019-01-09 | 0001144204-19-001220 | $ 2,596,282 | View |
| 2019-03-01 | 2019-05-31 | CY2018Q2 | 2019-07-03 | 0001144204-19-033793 | $ 2,602,465 | View |
| 2019-06-01 | 2019-08-31 | CY2018Q3 | 2019-10-08 | 0001144204-19-047666 | $ 2,605,186 | View |
| 2019-09-01 | 2019-11-30 | CY2018Q4 | 2020-01-10 | 0001104659-20-003044 | $ 2,610,490 | View |
| 2019-03-01 | 2020-02-29 | CY2018 | 2020-05-04 | 0001104659-20-055760 | $ 2,610,315 | View |
| 2020-03-01 | 2020-05-31 | CY2019Q2 | 2020-07-07 | 0001104659-20-081769 | $ 2,704,587 | View |
| 2021-04-01 | 2021-06-30 | CY2021Q2 | 2021-08-16 | 0001437749-21-019983 | $ 12,874,961 | View |
| 2021-07-01 | 2021-09-30 | CY2021Q3 | 2021-11-15 | 0001437749-21-026621 | $ 18,455,586 | View |
| 2021-01-01 | 2021-12-31 | CY2021Q4I | 2022-03-15 | 0001437749-22-006332 | $ 39,929 | View |
| 2022-01-01 | 2022-06-30 | CY2022Q2I | 2022-08-15 | 0001437749-22-020538 | $ 0 | View |
| 2022-01-01 | 2022-09-30 | CY2022Q3I | 2022-11-14 | 0001437749-22-027265 | $ 11 | View |
| 2022-01-01 | 2022-12-31 | CY2022Q4I | 2023-03-30 | 0001437749-23-008502 | $ 0 | View |
| 2023-01-01 | 2023-03-31 | CY2023Q1I | 2023-05-15 | 0001437749-23-014582 | $ 667,500 | View |
| 2023-01-01 | 2023-06-30 | CY2023Q2I | 2023-08-14 | 0001437749-23-023686 | $ 4 | View |
| 2023-01-01 | 2023-09-30 | CY2023Q3I | 2023-11-14 | 0001437749-23-031973 | $ 4 | View |
| 2023-01-01 | 2023-12-31 | CY2022Q4I | 2024-04-15 | 0001437749-24-011955 | $ 400,490 | View |
| 2024-01-01 | 2024-03-31 | CY2024Q1 | 2024-05-14 | 0001437749-24-016366 | $ 11,200 | View |
| 2024-04-01 | 2024-06-30 | CY2024Q2I | 2024-08-14 | 0001437749-24-026571 | $ 819,721 | View |
| 2024-01-01 | 2024-12-31 | CY2024 | 2025-04-03 | 0001437749-25-010791 | $ 900,000 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| us-gaap | Additional Paid in Capital | Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. | View |
| us-gaap | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | View |
| us-gaap | Convertible Notes Payable, Noncurrent | Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. | View |
| us-gaap | Debt Conversion, Converted Instrument, Amount | "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Debt Conversion, Original Debt, Amount | "The amount of the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Debt Instrument, Convertible, Conversion Price | The price per share of the conversion feature embedded in the debt instrument. | View |
| us-gaap | Earnings Per Share, Basic and Diluted | The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Liabilities | Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. | View |
| us-gaap | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. | View |
| us-gaap | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. | View |
| us-gaap | Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount | As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Temporary Equity, Accretion to Redemption Value, Adjustment | Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders. | View |
| us-gaap | Temporary Equity, Shares Issued | The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic and Diluted | Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Current State and Local Tax Expense (Benefit) | Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Foreign | The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile. | View |
| us-gaap | Money Market Funds, at Carrying Value | Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months. | View |
| us-gaap | Number of Operating Segments | Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues. | View |
| us-gaap | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return. | View |
| us-gaap | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. | View |
| us-gaap | Unrecognized Tax Benefits, Period Increase (Decrease) | Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns. | View |
| us-gaap | Current Federal Tax Expense (Benefit) | Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Current Foreign Tax Expense (Benefit) | Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Current Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. | View |
| us-gaap | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. | View |
| us-gaap | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Interest Income (Expense), Net | The net amount of operating interest income (expense). | View |
| us-gaap | Cash, FDIC Insured Amount | The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. | View |
| us-gaap | Class of Warrant or Right, Exercise Price of Warrants or Rights | Exercise price per share or per unit of warrants or rights outstanding. | View |
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| dei | Entity Public Float | The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. | View |
| us-gaap | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. | View |
| us-gaap | Common Stock, No Par Value | Face amount per share of no-par value common stock. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature. | View |
| us-gaap | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. | View |
| us-gaap | Share-based Payment Arrangement, Expense | Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. | View |
| us-gaap | Amortization of Debt Discount (Premium) | Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. | View |
| us-gaap | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets Held-in-trust | The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations. | View |
| us-gaap | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash and Cash Equivalents, Period Increase (Decrease) | Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | View |
| us-gaap | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | View |
| us-gaap | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Convertible Debt | Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. | View |
| us-gaap | Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction. | View |
| us-gaap | Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued | The total fair value of shares issued during the period under a deferred compensation arrangement. | View |
| us-gaap | Deferred Compensation Arrangement with Individual, Shares Issued | Number of shares issued pursuant to the terms of a deferred compensation arrangement. | View |
| us-gaap | Deferred Tax Assets, Gross | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Deferred Tax Assets, Net of Valuation Allowance | Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Tax Credit Carryforwards | Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards. | View |
| us-gaap | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. | View |
| us-gaap | Deferred Tax Assets, Valuation Allowance | Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Defined Contribution Plan, Employer Discretionary Contribution Amount | Amount of discretionary contributions made by an employer to a defined contribution plan. | View |
| us-gaap | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. | View |
| us-gaap | Derivative Liability, Current | Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. | View |
| us-gaap | Derivative Liability, Noncurrent | Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. | View |
| us-gaap | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. | View |
| us-gaap | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Percent | Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | Amount of cost not yet recognized for nonvested award under share-based payment arrangement. | View |
| us-gaap | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. | View |
| us-gaap | Gain (Loss) on Derivative Instruments, Net, Pretax | Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | View |
| us-gaap | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Income Taxes Paid | The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). | View |
| us-gaap | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). | View |
| us-gaap | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. | View |
| us-gaap | Increase (Decrease) in Deferred Liabilities | Change during the period in carrying value for all deferred liabilities due within one year or operating cycle. | View |
| us-gaap | Increase (Decrease) in Interest Payable, Net | The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity. | View |
| us-gaap | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. | View |
| us-gaap | Interest and Other Income | The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). | View |
| us-gaap | Interest Expense | Amount of the cost of borrowed funds accounted for as interest expense. | View |
| us-gaap | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. | View |
| us-gaap | Liabilities Assumed | The fair value of liabilities assumed in noncash investing or financing activities. | View |
| us-gaap | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | View |
| us-gaap | Marketable Securities, Unrealized Gain (Loss) | Amount of unrealized gain (loss) on investment in marketable security. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | View |
| us-gaap | Net Income (Loss) Available to Common Stockholders, Basic | Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. | View |
| us-gaap | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). | View |
| us-gaap | Notes Payable, Related Parties, Noncurrent | The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle). | View |
| us-gaap | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. | View |
| us-gaap | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. | View |
| us-gaap | Payments for Repurchase of Equity | The cash outflow to reacquire common and preferred stock. | View |
| us-gaap | Payments for Underwriting Expense | Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies. | View |
| us-gaap | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. | View |
| us-gaap | Payments to Acquire Restricted Investments | The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions. | View |
| us-gaap | Preferred Stock, No Par Value | Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer. | View |
| us-gaap | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | View |
| us-gaap | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Preferred Stock, Shares Issued | Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. | View |
| us-gaap | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | View |
| us-gaap | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. | View |
| us-gaap | Proceeds from Convertible Debt | The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. | View |
| us-gaap | Proceeds from Issuance or Sale of Equity | The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. | View |
| us-gaap | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | View |
| us-gaap | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Repayments of Related Party Debt | The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates. | View |
| us-gaap | Research and Development Expense | The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. | View |
| us-gaap | Restricted Investments, Noncurrent | This element represents the noncurrent portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions. | View |
| us-gaap | Retained Earnings (Accumulated Deficit) | The cumulative amount of the reporting entity's undistributed earnings or deficit. | View |
| us-gaap | Sale of Stock, Consideration Received on Transaction | Cash received on stock transaction after deduction of issuance costs. | View |
| us-gaap | Share-based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | The estimated amount of dividends to be paid to holders of the underlying shares (expected dividends) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Gross number of share options (or share units) granted during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Number of options outstanding, including both vested and non-vested options. | View |
| us-gaap | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | Number of shares issued under share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. | View |
| us-gaap | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate | The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the expected term of a nonvested share or option award issued to other than an employee. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | Number of options vested. | View |
| us-gaap | Share Price | Price of a single share of a number of saleable stocks of a company. | View |
| us-gaap | Stockholders' Equity Attributable to Parent | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | View |
| us-gaap | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. | View |
| us-gaap | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. | View |
| us-gaap | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. | View |
| us-gaap | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. | View |
| us-gaap | Stock Redeemed or Called During Period, Shares | Number of stock bought back by the entity at the exercise price or redemption price. | View |
| us-gaap | Stock Repurchased During Period, Value | Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. | View |
| us-gaap | Unrecognized Tax Benefits | Amount of unrecognized tax benefits. | View |
| us-gaap | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. | View |
| us-gaap | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate. | View |
| us-gaap | Deferred Income Tax Expense (Benefit) | Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Issuance of Stock and Warrants for Services or Claims | Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. | View |
| us-gaap | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. | View |
| us-gaap | Stock Issued During Period, Shares, Issued for Services | Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. | View |
| us-gaap | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. | View |
| us-gaap | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | View |
| us-gaap | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. | View |
| us-gaap | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | The risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | The maximum risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | The minimum risk-free interest rate assumption that is used in valuing an option on its own shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. | View |
| us-gaap | Deferred Federal Income Tax Expense (Benefit) | Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Deferred Foreign Income Tax Expense (Benefit) | Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Deferred State and Local Income Tax Expense (Benefit) | Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Deferred Tax Assets, Other | Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Domestic | The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. | View |
| us-gaap | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit | The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date. | View |
| us-gaap | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. | View |
| us-gaap | Proceeds from Short-term Debt | The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. | View |
| us-gaap | Short-term Debt | Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer. | View |
| us-gaap | Repayments of Short-term Debt | The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. | View |
| us-gaap | Class of Warrant or Right, Outstanding | Number of warrants or rights outstanding. | View |
| us-gaap | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. | View |
| us-gaap | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. | View |
| us-gaap | Operating Lease, Expense | Amount of operating lease expense. Excludes sublease income. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Warrant Issued | Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. | View |
| us-gaap | Cash and Due from Banks | For banks and other depository institutions: Includes cash on hand (currency and coin), cash items in process of collection, noninterest bearing deposits due from other financial institutions (including corporate credit unions), and noninterest bearing balances with the Federal Reserve Banks, Federal Home Loan Banks and central banks. | View |
| us-gaap | Cash, Uninsured Amount | The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. | View |
| us-gaap | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. | View |
| us-gaap | Common Stock, Capital Shares Reserved for Future Issuance | Aggregate number of common shares reserved for future issuance. | View |
| us-gaap | 263713 | None | View |
| us-gaap | Prepaid Expense, Noncurrent | Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Additional Paid in Capital | View |
| Amortization of Debt Discount (Premium) | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | View |
| Debt Conversion, Converted Instrument, Amount | View |
| Debt Conversion, Original Debt, Amount | View |
| Debt Instrument, Convertible, Conversion Price | View |
| Marketable Securities, Unrealized Gain (Loss) | View |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | View |
| Stock Repurchased During Period, Value | View |
| Temporary Equity, Accretion to Redemption Value, Adjustment | View |
| Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | View |
| Unrecognized Tax Benefits that Would Impact Effective Tax Rate | View |
| Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | View |
| Number of Operating Segments | View |
| Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | View |
| Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | View |
| Unrecognized Tax Benefits, Period Increase (Decrease) | View |
| Accounts Payable, Current | View |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | View |
| Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | View |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | View |
| Share-based Payment Arrangement, Expense | View |
| Assets | View |
| Assets, Current | View |
| Assets Held-in-trust | View |
| Cash and Cash Equivalents, at Carrying Value | View |
| Cash and Cash Equivalents, Period Increase (Decrease) | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | View |
| Cash, FDIC Insured Amount | View |
| Class of Warrant or Right, Exercise Price of Warrants or Rights | View |
| Common Stock, No Par Value | View |
| Common Stock, Par or Stated Value Per Share | View |
| Common Stock, Shares Authorized | View |
| Common Stock, Shares, Issued | View |
| Common Stock, Shares, Outstanding | View |
| Common Stock, Value, Issued | View |
| Convertible Debt | View |
| Convertible Notes Payable, Noncurrent | View |
| Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | View |
| Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued | View |
| Deferred Compensation Arrangement with Individual, Shares Issued | View |
| Deferred Tax Assets, Gross | View |
| Deferred Tax Assets, Net of Valuation Allowance | View |
| Deferred Tax Assets, Operating Loss Carryforwards | View |
| Deferred Tax Assets, Tax Credit Carryforwards | View |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | View |
| Deferred Tax Assets, Valuation Allowance | View |
| Defined Contribution Plan, Employer Discretionary Contribution Amount | View |
| Depreciation | View |
| Derivative Liability, Current | View |
| Derivative Liability, Noncurrent | View |
| Earnings Per Share, Basic and Diluted | View |
| Effective Income Tax Rate Reconciliation, Percent | View |
| Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | View |
| Fair Value Adjustment of Warrants | View |
| Gain (Loss) on Derivative Instruments, Net, Pretax | View |
| General and Administrative Expense | View |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | View |
| Income Tax Expense (Benefit) | View |
| Income Taxes Paid | View |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | View |
| Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | View |
| Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | View |
| Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | View |
| Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | View |
| Increase (Decrease) in Accounts Payable | View |
| Increase (Decrease) in Deferred Liabilities | View |
| Increase (Decrease) in Interest Payable, Net | View |
| Increase (Decrease) in Prepaid Expense and Other Assets | View |
| Interest and Other Income | View |
| Interest Expense | View |
| Interest Income (Expense), Net | View |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | View |
| Investment Income, Interest | View |
| Liabilities | View |
| Liabilities and Equity | View |
| Liabilities Assumed | View |
| Liabilities, Current | View |
| Net Cash Provided by (Used in) Financing Activities | View |
| Net Cash Provided by (Used in) Investing Activities | View |
| Net Cash Provided by (Used in) Operating Activities | View |
| Net Income (Loss) Attributable to Parent | View |
| Net Income (Loss) Available to Common Stockholders, Basic | View |
| Nonoperating Income (Expense) | View |
| Notes Payable, Related Parties, Noncurrent | View |
| Operating Expenses | View |
| Operating Income (Loss) | View |
| Payments for Repurchase of Equity | View |
| Payments for Underwriting Expense | View |
| Payments of Stock Issuance Costs | View |
| Payments to Acquire Restricted Investments | View |
| Preferred Stock, No Par Value | View |
| Preferred Stock, Par or Stated Value Per Share | View |
| Preferred Stock, Shares Authorized | View |
| Preferred Stock, Shares Issued | View |
| Preferred Stock, Shares Outstanding | View |
| Preferred Stock, Value, Issued | View |
| Prepaid Expense and Other Assets, Current | View |
| Proceeds from Convertible Debt | View |
| Proceeds from Issuance of Common Stock | View |
| Proceeds from Issuance of Private Placement | View |
| Proceeds from Issuance or Sale of Equity | View |
| Proceeds from Related Party Debt | View |
| Property, Plant and Equipment, Net | View |
| Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount | View |
| Repayments of Related Party Debt | View |
| Research and Development Expense | View |
| Restricted Investments, Noncurrent | View |
| Retained Earnings (Accumulated Deficit) | View |
| Sale of Stock, Consideration Received on Transaction | View |
| Share-based Payment Arrangement, Noncash Expense | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | View |
| Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | View |
| Share Price | View |
| Stockholders' Equity Attributable to Parent | View |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | View |
| Stock Issued During Period, Value, Conversion of Convertible Securities | View |
| Stock Issued During Period, Value, New Issues | View |
| Stock Issued During Period, Value, Other | View |
| Stock Redeemed or Called During Period, Shares | View |
| Temporary Equity, Shares Issued | View |
| Unrecognized Tax Benefits | View |
| Weighted Average Number of Shares Outstanding, Basic and Diluted | View |
| Deferred Income Tax Expense (Benefit) | View |
| Issuance of Stock and Warrants for Services or Claims | View |
| Proceeds from Warrant Exercises | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | View |
| Stock Issued During Period, Shares, Issued for Services | View |
| Stock Issued During Period, Value, Issued for Services | View |
| Earnings Per Share, Basic | View |
| Weighted Average Number of Shares Outstanding, Basic | View |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | View |
| Cash | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | View |
| Current Federal Tax Expense (Benefit) | View |
| Current Foreign Tax Expense (Benefit) | View |
| Current Income Tax Expense (Benefit) | View |
| Current State and Local Tax Expense (Benefit) | View |
| Deferred Federal Income Tax Expense (Benefit) | View |
| Deferred Foreign Income Tax Expense (Benefit) | View |
| Deferred State and Local Income Tax Expense (Benefit) | View |
| Deferred Tax Assets, Other | View |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | View |
| Income (Loss) from Continuing Operations before Income Taxes, Foreign | View |
| Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit | View |
| Other Nonoperating Income (Expense) | View |
| Proceeds from Short-term Debt | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | View |
| Short-term Debt | View |
| Repayments of Short-term Debt | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | View |
| Class of Warrant or Right, Outstanding | View |
| Employee-related Liabilities, Current | View |
| Effective Income Tax Rate Reconciliation, Tax Credit, Amount | View |
| Other Accrued Liabilities, Current | View |
| Operating Lease, Expense | View |
| Adjustments to Additional Paid in Capital, Warrant Issued | View |
| Cash and Due from Banks | View |
| Cash, Uninsured Amount | View |
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights | View |
| Common Stock, Capital Shares Reserved for Future Issuance | View |
| 261416 | View |
| Money Market Funds, at Carrying Value | View |
| Prepaid Expense, Noncurrent | View |